These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9019170)

  • 1. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism.
    Gasdaska JR; Berggren M; Powis G
    Cell Growth Differ; 1995 Dec; 6(12):1643-50. PubMed ID: 9019170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells.
    Gallegos A; Gasdaska JR; Taylor CW; Paine-Murrieta GD; Goodman D; Gasdaska PY; Berggren M; Briehl MM; Powis G
    Cancer Res; 1996 Dec; 56(24):5765-70. PubMed ID: 8971189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thioredoxin/thioredoxin reductase redox system and control of cell growth.
    Powis G; Oblong JE; Gasdaska PY; Berggren M; Hill SR; Kirkpatrick DL
    Oncol Res; 1994; 6(10-11):539-44. PubMed ID: 7620223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenium and the thioredoxin redox system: effects on cell growth and death.
    Powis G; Gasdaska JR; Gasdaska PY; Berggren M; Kirkpatrick DL; Engman L; Cotgreave IA; Angulo M; Baker A
    Oncol Res; 1997; 9(6-7):303-12. PubMed ID: 9406236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
    Gallegos A; Berggren M; Gasdaska JR; Powis G
    Cancer Res; 1997 Nov; 57(21):4965-70. PubMed ID: 9354464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia.
    Berggren M; Gallegos A; Gasdaska JR; Gasdaska PY; Warneke J; Powis G
    Anticancer Res; 1996; 16(6B):3459-66. PubMed ID: 9042207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.
    Engman L; Cotgreave I; Angulo M; Taylor CW; Paine-Murrieta GD; Powis G
    Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox control of caspase-3 activity by thioredoxin and other reduced proteins.
    Baker A; Santos BD; Powis G
    Biochem Biophys Res Commun; 2000 Feb; 268(1):78-81. PubMed ID: 10652216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
    Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
    Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.
    Liu Y; Ludes-Meyers J; Zhang Y; Munoz-Medellin D; Kim HT; Lu C; Ge G; Schiff R; Hilsenbeck SG; Osborne CK; Brown PH
    Oncogene; 2002 Oct; 21(50):7680-9. PubMed ID: 12400010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells.
    Rubartelli A; Bonifaci N; Sitia R
    Cancer Res; 1995 Feb; 55(3):675-80. PubMed ID: 7834639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-directed mutagenesis of active site cysteines in human thioredoxin produces competitive inhibitors of human thioredoxin reductase and elimination of mitogenic properties of thioredoxin.
    Oblong JE; Berggren M; Gasdaska PY; Powis G
    J Biol Chem; 1994 Apr; 269(16):11714-20. PubMed ID: 8163468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cell growth-promoting factor identified in a B cell leukemia cell line, BALL-1.
    Dao T; Holán V; Minowada J
    Neoplasma; 1993; 40(5):265-73. PubMed ID: 8272154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.
    Sartor CI; Dziubinski ML; Yu CL; Jove R; Ethier SP
    Cancer Res; 1997 Mar; 57(5):978-87. PubMed ID: 9041204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF, TGF alpha, AR and HB-EGF are autocrine growth factors for human bladder carcinoma cell lines.
    Ruck A; Paulie S
    Anticancer Res; 1998; 18(3A):1447-52. PubMed ID: 9673354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor as an autocrine growth factor for neuroblastoma.
    Goillot E; Combaret V; Ladenstein R; Baubet D; Blay JY; Philip T; Favrot MC
    Cancer Res; 1992 Jun; 52(11):3194-200. PubMed ID: 1317260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult T cell leukemia (ATL)-derived factor/human thioredoxin prevents apoptosis of lymphoid cells induced by L-cystine and glutathione depletion: possible involvement of thiol-mediated redox regulation in apoptosis caused by pro-oxidant state.
    Iwata S; Hori T; Sato N; Hirota K; Sasada T; Mitsui A; Hirakawa T; Yodoi J
    J Immunol; 1997 Apr; 158(7):3108-17. PubMed ID: 9120263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
    Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
    Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
    Spens E; Häggström L
    Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.